HOWL Q3 2024 Earnings — Werewolf Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HOWLWerewolf Therapeutics, Inc.

$35M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$17M

Net Income

-$17M

EPS (Diluted)

$-0.38

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$140M

Total Liabilities

$51M

Stockholders' Equity

$89M

Cash & Equivalents

$123M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$6M	-100.0%
Gross Profit	$0	$5M	-100.0%
Operating Income	-$17M	-$9M	-85.1%
Net Income	-$17M	-$8M	-101.2%